Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.94 USD | -3.11% | -0.53% | +16.04% |
30/04 | North American Morning Briefing : More Earnings -2- | DJ |
29/04 | Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.04% | 2.53B | |
+9.78% | 106B | |
+0.97% | 104B | |
+6.72% | 23.25B | |
-13.75% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.87% | 16.99B | |
+8.24% | 14.26B | |
+38.91% | 12.76B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- PTC Therapeutics : Credit Suisse Lowers PTC Therapeutics' PT to $50 from $54, Keeps Neutral Rating